ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag placebo genetics genomics

Recent Trials for Fragile X Syndrome Offer Hope
Randi Hagerman | Sep 1, 2019 | 10+ min read
Despite a solid understanding of the biological basis of fragile X syndrome, researchers have struggled to develop effective treatments.
Notebook
The Scientist Staff | Apr 26, 1998 | 8 min read
WHAT FOLLOWS TAMOXIFEN? Warnings accompanied recent announcements from the University of Pittsburgh-based National Surgical Adjuvant Breast and Bowel Project and the National Cancer Institute in Bethesda, Md., that tamoxifen achieved a 45 percent reduction in the incidence of breast cancer compared to women who took a placebo in the Breast Cancer Prevention Trial. The 25-year-old drug still carries the risk of serious side effects for women over 50, officials said. But the overall results were
Notebook
The Scientist Staff | Mar 2, 1997 | 8 min read
Monday mornings can be tough, even if you're Bill Gates. The head of Redmond, Wash.-based Microsoft Corp. ran into a few glitches at a presentation he was giving at the annual meeting of the American Association for the Advancement of Science (AAAS) in Seattle. In the middle of a demonstration on February 17 aimed at showing how Web browsers and E-mail will soon merge, the modem connection failed. A computer-vision demonstration by a Microsoft researcher didn't work, either. Then, during a ques

Run a Search

ADVERTISEMENT